FDA Approvals

Date Posted
Article Title
3/24/2015
New Blood Pump System Approved

Maintains circulation during riskier cardiac surgery

3/18/2015
Cholbam Approved for Rare Metabolic Disorders

Conditions affect liver and vitamin absorption

3/10/2015
Unituxin Approved for Deadly Pediatric Cancer

Neuroblastoma typically strikes children under age 5

3/9/2015
New CPR Devices Approved

May help more people survive cardiac arrest, FDA says

3/6/2015
First Biosimilar Drug Approved

Zarxio is 'highly similar' to long-sanctioned cancer drug

3/6/2015
Cresemba Approved for Serious Fungal Infections

Most often these illnesses affect people with weakened immune systems

3/6/2015
3/4/2015
Opdivo Approval Expanded to Include Lung Cancer

The leading cause of cancer death in the U.S.

2/26/2015
New Antibiotic Avycaz Approved

Combination drug sanctioned for abdominal, urinary tract infections

2/24/2015
Farydak Approved for Multiple Myeloma

Blood cancer kills more than 10,000 Americans annually

2/20/2015
New Device Treats Superficial Varicose Veins

Adhesive product cuts off blood supply in unsightly leg vessels

2/13/2015
Lenvima Approved for Common Thyroid Cancer

Recommended for use if radioactive iodine fails to stop progression

2/13/2015
Device Approved for Female Fecal Incontinence

Use of Eclipse System led to 50 percent decrease in episodes

2/9/2015
New Device Cleared to Reduce Stroke Risk

First approved device designed to enter artery through neck, not groin

2/9/2015
Lucentis Approved for Diabetic Retinopathy

Among diabetics with macular edema

2/4/2015
Internal Tissue Adhesive Approved

TissuGlu connects tissue flaps stemming from surgery to remove excess fat, skin from stomach

2/4/2015
2/2/2015
Vyvanse Approved for Binge-Eating Disorder

Characterized by compulsive overeating

1/26/2015
Generic Form of Nexium Approved

Drug used to ease chronic heartburn

1/26/2015
Natpara Approved for Hormone Disorder Causing Low Blood Calcium

Drug is for people with insufficient parathyroid hormone